Free Trial
→ Many investors are about to lose everything (From Porter & Company) (Ad)tc pixel
OTCMKTS:CURLF

Curaleaf Q2 2026 Earnings Results & Report

Curaleaf logo
$9.37 -0.07 (-0.74%)
As of 11/6/2026 03:59 PM Eastern

Curaleaf beat analyst expectations on both earnings and revenue in its Q2 2026 results, released August 5, 2026. The company reported EPS of $0.05 versus the -$0.20 consensus estimate, while revenue of $340.10 million topped the $332 million estimate by $8.10 million.

Research:ProfileEarnings HistoryForecast

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
After Market Closes

Curaleaf EPS Results

Actual EPS
$0.05
Consensus EPS
-$0.20
Beat/Miss
Beat by +$0.25
One Year Ago EPS
N/A
EPS Beat Rate
7 of last 8 quarters

Curaleaf Revenue Results

Actual Revenue
$340.10 million
Expected Revenue
$332 million
Beat/Miss
Beat by +$8.10 million
YoY Revenue Growth
N/A

Conference Call Resources

Curaleaf Q2 2026 Earnings FAQ

Curaleaf (OTCMKTS:CURLF) reported earnings of $0.05 per share for Q2 2026, beating the consensus estimate of -$0.20. The report was announced on Wednesday, August 5, 2026.

Curaleaf reported revenue of $340.10 million for Q2 2026, against a consensus estimate of $332 million.

Curaleaf Earnings Headlines

Curaleaf Issues Statement Regarding Alternative Proposal for Aurora Cannabis
November 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/curaleaf-issues-statement-regarding-alternative-proposal-for-aurora-cannabis-302928528.html
Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability
November 3, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/curaleaf-reports-third-quarter-2026-results-record-revenue-and-robust-profitability-302928414.html
A free stock pick, from me to you
Elon's paid this chip supplier since 2012. When NVIDIA tried to buy the company, he fought the deal. Without its chip, his AI satellites don't fly. Now he wants 1,000,000 of them in orbit, 100 times what's up there today, and every one pays this company a royalty. Dylan believes shares could react by December 8th.tc pixel
November 8 at 1:00 AM  |  Behind the Markets (Ad)
Curaleaf Acquires Equity Interest in Boone Town Provisions, Expanding New Jersey Footprint to Four Dispensaries
November 2, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/curaleaf-acquires-equity-interest-in-boone-town-provisions-expanding-new-jersey-footprint-to-four-dispensaries-302925985.html
Curaleaf Celebrates Graduation of Inaugural New York Incubator Program Class, Announces Future Cohorts and Multi-State Expansion
October 30, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/curaleaf-celebrates-graduation-of-inaugural-new-york-incubator-program-class-announces-future-cohorts-and-multi-state-expansion-302924932.html
Aurora Cannabis Announces the Alberta Securities Commission has dismissed Curaleaf's Application and ruled in favour of the Company's At-the-Market Program
October 26, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/aurora-cannabis-announces-the-alberta-securities-commission-has-dismissed-curaleafs-application-and-ruled-in-favour-of-the-companys-at-the-market-program-302919349.html
See More Curaleaf Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Curaleaf? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Curaleaf and other key companies, straight to your email.

About Curaleaf

Curaleaf (OTCMKTS:CURLF) is a cannabis company that cultivates, processes, distributes and sells cannabis products for medical and adult-use markets. Its portfolio includes cannabis flower, pre-rolls, vaporizers, concentrates, edibles, tinctures, capsules, topicals and other wellness products, offered under brands such as Curaleaf, Select and Grassroots.

The company serves customers through a network of retail dispensaries and wholesale channels in regulated U.S. cannabis markets. Its operations include cultivation and manufacturing facilities as well as dispensaries, with products distributed in multiple states where medical or adult-use cannabis is permitted. Curaleaf has also pursued international opportunities, particularly in European medical-cannabis markets.

Curaleaf traces its origins to 2010 and has expanded through organic growth and acquisitions, including the purchase of Select in 2019 and Grassroots in 2020. Boris Jordan serves as executive chairman, and Matt Darin has served as chief executive officer. The company’s shares trade over the counter under the symbol CURLF.

View Curaleaf Profile
Earnings Tools